抜粋
Glucocorticoid-induced osteoporosis (GIOP) is known as a serious adverse side effect during long-term glucocorticoid treatment. Several clinical guidelines are available to whom and how we should start to treat GIOP. However, the assessment of the treatment of GIOP is still controversial. Accumulating evidences suggest us that both bone mineral density and bone turn over markers could reflect the effect of some pharmacological agents on bone metabolism. However, further studies would be required for precise assessment of the efficacy of drugs on fracture prevention in GIOP.
| 元の言語 | English |
|---|---|
| ページ（範囲） | 401-408 |
| ページ数 | 8 |
| ジャーナル | Unknown Journal |
| 巻 | 23 |
| 発行部数 | 3 |
| 出版物ステータス | Published - 03-2013 |
All Science Journal Classification (ASJC) codes
- Medicine(all)
フィンガープリント [Assessment of the treatment of glucocorticoid-induced osteoporosis].' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。
これを引用
Asano, S., & Suzuki, A. (2013). [Assessment of the treatment of glucocorticoid-induced osteoporosis]. Unknown Journal, 23(3), 401-408.